Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on November 6, 2018. The report addresses a change in the listing status of the Company's common stock on The Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory listing status rather than financial performance metrics.
Material Changes
- Listing Transfer: Nasdaq approved the transfer of Pulmatrix's common stock from the Nasdaq Global Market to the Nasdaq Capital Market, effective November 7, 2018.
- Reason for Transfer: The Company previously failed to meet the minimum bid price requirement of $1.00 per share for the Nasdaq Global Market (notified May 8, 2018).
- Trading Symbol: The stock will continue to trade under the symbol "PULM".
Outlook, Risks, and Contingencies
- Grace Period: The Company has been granted an 180-day grace period ending May 6, 2019, to regain compliance with the $1.00 minimum bid price requirement.
- Compliance Requirement: To maintain listing on the Nasdaq Capital Market, the stock must trade at or above $1.00 for at least ten consecutive business days within the grace period.
- Delisting Risk: Failure to regain compliance by the end of the grace period will result in the delisting of the Company's common stock by Nasdaq.
Investor Verification Checklist
- Verify the current trading price of "PULM" to assess proximity to the $1.00 minimum bid price threshold.
- Monitor the stock's performance over the next 180 days to determine if the ten-day consecutive trading requirement is met.
- Review subsequent filings for any updates on the Company's efforts to regain compliance or potential delisting notices.